Renovis

BiotechnologySeries ESouth San Francisco, US

Latest round

Series E

Last raised

Aug 2003

Total raised

$95M

Investors

15

About Renovis

Renovis is a US based bio pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of neurological and inflammatory diseases.

Who invested in Renovis

15 investors across 3 rounds

See all investors in Renovis

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Aug 11, 2003

    Amount

    $45M

    Investors

    Locked

  2. Series B

    Jan 9, 2002

    Amount

    $34M

    Investors

    Locked

  3. Series A

    Jul 1, 2000

    Amount

    $16M

    Investors

    Locked

Questions about Renovis

Who invested in Renovis?

Renovis has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Renovis raised?

Renovis has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Renovis last raise money?

Renovis's most recent round on record is a Series E, in Aug 2003.

What does Renovis do?

Renovis is a US based bio pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of neurological and inflammatory diseases.

Where is Renovis headquartered?

Renovis is headquartered in South San Francisco, US.

Which VCs invest in companies like Renovis?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Renovis's stage. Their profiles are linked below.

Raising like Renovis? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.